Bids are Invited For Tab calpol 650,Tab Intadol SP,Syp Intacid MPS 170 ml,Tab Vomisheild 4MD,Tab Criticold plus,Tab Phen in KANKER, CHHATTISGARH

The eligibility requirements include being a registered entity with the necessary legal compliance, demonstrating experience in supplying pharmaceutical products, and meeting turnover criteria. Bidders must also provide the required certificates, such as OEM Authorization Certificates and financial documents to showcase their financial stability. Additionally, for those seeking exemption from particular experience or turnover criteria, supporting documents must be submitted for evaluation.

The required certificates typically include an OEM Authorization Certificate, financial confirmation documents that validate the bidder’s turnover, and any other certifications explicitly mentioned in the tender. Compliance with standards set by regulatory bodies in the pharmaceutical field is also mandatory to ensure quality and safety.

To participate, bidders must complete the registration process through the official Government E-Marketplace (GEM) portal. This involves providing details of the business entity, uploading the necessary documentation, and complying with all registration requisites as outlined in the tender documents.

Bidders are generally required to submit documents in PDF format unless otherwise specified in the tender guidelines. All submissions must be clear and legible to facilitate proper evaluation.

The technical specifications will include detailed descriptions of the pharmaceutical products listed, including their formulation, dosage, and regulatory requirements. Bidders must ensure that their products align with the specified quality assurance processes required by the Central Armed Police Forces.

Yes, the tender demands compliance with recognized quality standards pertaining to pharmaceutical products. Bidders must demonstrate adherence to these standards, providing necessary documentation and certifications during the submission process.

Bidders must comply with all relevant regulatory norms governing the supply of pharmaceutical products. This includes adhering to safety standards, quality certifications, and ensuring that all products meet the specifications laid out in the tender.

The Earnest Money Deposit (EMD) is a specified amount that bidders must submit alongside their proposals to demonstrate serious intent. The exact amount along with the process for submission will be detailed in the tender documentation.

Performance security may be required post-award to ensure that the successful bidder fulfills their commitments. The specific terms regarding the amount and conditions will be outlined in the tender documents.

The payment terms will specify how and when payments will be made upon the successful delivery and acceptance of the products. Bidders should review these terms carefully in the tender documents to ensure alignment with their policies.

Price evaluation will involve assessing the bids on a total value basis, comparing the financial proposals of all participating bidders. This process ensures that the most economically advantageous offer is selected.

Bidders must submit their documents through the designated online platform on the Government E-Marketplace. The specifics regarding the submission process are elaborated in the tender guidelines.

Yes, while exact dates cannot be provided, bidders should carefully review the tender documents for important dates related to bid submission, opening, and any other critical milestones.

The evaluation and selection process involves an in-depth review of submitted proposals against predetermined criteria. Bidders' qualifications, compliance with technical requirements, and pricing structures will be carefully scrutinized to determine the successful candidate.

Notification of results will occur after the evaluation process has been completed. Bidders will be informed through official communication channels regarding the outcome of their submissions.

The tender includes special provisions aimed at promoting participation from Micro, Small, and Medium Enterprises (MSEs), offering relaxed eligibility criteria and allowing for competitive advantages in the evaluation process. Detailed information will be provided in the official tender documents.

Yes, there are provisions that favor startups, promoting their participation by possibly relaxing eligibility requirements and providing necessary incentives to encourage innovation and competitive bidding.

The tender aligns with the 'Make in India' initiative by promoting local manufacturing of pharmaceutical products, encouraging bidders to source locally and bolster the domestic economy as part of their bids.

Yes, the procurement process may incorporate elements of local content and procurement rules, incentivizing bidders who align their sourcing and production processes with local capabilities and resources, ensuring national benefits.